# Nippon Medical School

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/nippon-medical-school/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 51.3 |
| Citations | 1,533,657 |
| City | Tokyo |
| Country | JP |
| Description | Nippon Medical School is a research organisation in Tokyo, JP. OpenAlex records 26,237 works and 1,533,657 citations for it. 4,845 researchers list it as their most recent affiliation. |
| Homepage | http://college.nms.ac.jp/ |
| OpenAlex ID | https://openalex.org/I80188885 |
| Researchers | 4,845 |
| ROR ID | https://ror.org/00krab219 |
| Type | education |
| Wikidata ID | https://www.wikidata.org/wiki/Q615301 |
| Works | 26,237 |

## University papers

Showing 12 of 41.

- [Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer](https://scholariq.org/papers/durvalumab-after-chemoradiotherapy-in-stage-iii-non-small-cell-lung-cancer/)
- [Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial](https://scholariq.org/papers/pembrolizumab-versus-chemotherapy-for-previously-untreated-pd-l1-expressing/)
- [Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC](https://scholariq.org/papers/overall-survival-with-durvalumab-after-chemoradiotherapy-in-stage-iii-nsclc/)
- [Frequent pathway mutations of splicing machinery in myelodysplasia](https://scholariq.org/papers/frequent-pathway-mutations-of-splicing-machinery-in-myelodysplasia/)
- [Haploinsufficiency of NSD1 causes Sotos syndrome](https://scholariq.org/papers/haploinsufficiency-of-nsd1-causes-sotos-syndrome/)
- [Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia](https://scholariq.org/papers/somatic-mutations-and-clonal-hematopoiesis-in-aplastic-anemia/)
- [Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan](https://scholariq.org/papers/randomized-phase-iii-study-of-cisplatin-plus-irinotecan-versus-carboplatin-plus/)
- [Cutting Edge: Secondary Lymphoid-Tissue Chemokine (SLC) and CC Chemokine Receptor 7 (CCR7) Participate in the Emigration Pathway of Mature Dendritic Cells from the Skin to Regional Lymph Nodes](https://scholariq.org/papers/cutting-edge-secondary-lymphoid-tissue-chemokine-slc-and-cc-chemokine-receptor-7/)
- [Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*](https://scholariq.org/papers/tralokinumab-for-moderate-to-severe-atopic-dermatitis-results-from-two-52-week/)
- [Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity](https://scholariq.org/papers/thymus-and-activation-regulated-chemokine-in-atopic-dermatitis-serum-thymus-and/)
- [Kabuki make-up syndrome: A syndrome of mentalretardation, unusual facies, large and protruding ears, and postnatal growth deficiency](https://scholariq.org/papers/kabuki-make-up-syndrome-a-syndrome-of-mentalretardation-unusual-facies-large-and/)
- [Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome](https://scholariq.org/papers/mutations-affecting-components-of-the-swi-snf-complex-cause-coffin-siris/)

## University researchers

- [Yoshimitsu Fukushima](https://scholariq.org/researchers/yoshimitsu-fukushima/)
- [Hidehisa Saeki](https://scholariq.org/researchers/hidehisa-saeki/)
- [Akira Teramoto](https://scholariq.org/researchers/akira-teramoto/)

## University top topics

Showing 8 of 25.

- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Cardiac electrophysiology and arrhythmias](https://scholariq.org/topics/cardiac-electrophysiology-and-arrhythmias/)
- [Cardiac Arrhythmias and Treatments](https://scholariq.org/topics/cardiac-arrhythmias-and-treatments/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.